Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.07
-0.07 (-0.98%)
At close: Dec 5, 2025, 4:00 PM EST
7.21
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:50 PM EST
Bicycle Therapeutics Revenue
Bicycle Therapeutics had revenue of $11.73M in the quarter ending September 30, 2025, with 338.49% growth. This brings the company's revenue in the last twelve months to $28.34M, down -23.20% year-over-year. In the year 2024, Bicycle Therapeutics had annual revenue of $35.28M with 30.76% growth.
Revenue (ttm)
$28.34M
Revenue Growth
-23.20%
P/S Ratio
17.27
Revenue / Employee
$92,915
Employees
305
Market Cap
490.43M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BCYC News
- 23 days ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 5 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn - Seeking Alpha
- 3 months ago - Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Bicycle Therapeutics Strengthens Board of Directors with New Appointments - Business Wire
- 4 months ago - Bicycle (BCYC) Q2 Revenue Falls 69% - The Motley Fool
- 4 months ago - Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - Business Wire
- 5 months ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire